Aspen sells six South African medicines to Swedish company
Swiss pharmaceutical company Acino and multinational pharmaceutical company Aspen Pharmacare and its subsidiaries have signed an agreement for Acino to acquire six South African medicines for more than R1.8-billion.
The acquired medicines are used for the treatment of gastroenterology, erectile dysfunction and cardiovascular diseases.
The acquisition will further strengthen Acino’s footprint in South Africa by expanding its offering in these important therapeutic segments.
The transaction includes the Trustan, Altosec, Zuvamor, Ciavor, Grantryl and Aspen Granisetron brands.
To secure uninterrupted patient access to these medicines, the parties have also signed a manufacturing and supply agreement in terms of which Aspen will supply the Aspen manufactured products to Acino for seven years.
In a statement on October 22, this partnership was said to be “a compelling affirmation” of Acino’s long-term strategy and purpose to increase people’s access to affordable healthcare in the areas where they need them most.
This acquisition by Acino comes on the heels of a series of other strategic investments, including its acquisition of a women’s health portfolio in Russia earlier this year and Takeda’s primary care portfolio in 2020.
“This agreement will fortify Acino’s presence in South Africa and enable us to expand our diverse portfolio of high-quality, innovative treatments that help improve people’s lives,” said Acino CEO Steffen Saltofte.
He added that Acino was committed to growing its footprint across its core emerging markets to deliver the best value to patients, customers, suppliers and shareholders.
Aspen group CE Stephen Saad, meanwhile, explained that the transaction formed part of Aspen’s communicated strategy to refine its product portfolio in South Africa.
“The acquisition of these trusted brands in South Africa represents excellent scaling and commercial opportunities for Acino as it expands its footprint in South Africa by adding these products to its existing product portfolio.”
The transaction is subject to customary closing conditions, including regulatory approvals. It is anticipated that the transaction will complete by December 31.
Comments
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation